Navigation Links
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
Date:7/27/2009

COLLEGEVILLE, Pa., July 27 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced the publication in Fertility and Sterility of data from a Phase 3 clinical study that showed that the investigational compound bazedoxifene/conjugated estrogens (BZA/CE) significantly reduced the frequency and severity of hot flushes and improved measures of vaginal atrophy when compared to placebo. In this study, uterine bleeding was not statistically different from placebo and the rate of endometrial hyperplasia in doses being considered for therapeutic use was <1%. BZA/CE is being studied by Wyeth Pharmaceuticals for the treatment of moderate-to-severe menopausal vasomotor symptoms such as hot flushes, night sweats and vulvar and vaginal atrophy, and for the prevention of postmenopausal osteoporosis.

The data, published online July 27, 2009 in the peer-reviewed journal Fertility and Sterility, is from the Selective estrogens Menopause And Response to Therapy (SMART-1) clinical trial. SMART-1 was designed to explore the hypothesis that bazedoxifene, when paired with conjugated estrogens, may have the potential to eliminate the need for progestin in menopausal therapy in women with an intact uterus. BZA/CE is characterized by Wyeth as a TSEC (tissue selective estrogen complex) as it combines a selective estrogen receptor modulator (SERM) with conjugated estrogens.

Across the SMART-1 trial, the incidence of treatment-emergent adverse events, breast pain, serious adverse events and withdrawals due to adverse events were similar among the active treatment groups and placebo.

About SMART-1

SMART-1 was a two-year, multinational, multicenter, randomized, double-blind, placebo- and active-control
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
3. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
9. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
10. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
11. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... LONDON , July 31, 2014 ... the medical industries, announced today the incorporation of genae UK in ... Kingdom has one of the largest medical device markets ... 2012 and it is projected to increase by a CAGR of ... in 2012, equal to 9.5% of GDP. Despite recessionary pressures, market ...
(Date:7/31/2014)... YORK , July 31, 2014 ... discovering and developing better, faster and affordable treatments, ... as Senior Vice President, External Affairs. Mr. Brock ... as Head of Major Donor Relations for WWF ... In his role, Mr. Brock will guide the ...
(Date:7/31/2014)... , July 31, 2014  Genomic Health, Inc. (Nasdaq: ... host a conference call and webcast on Thursday, August 7 ... 2014 financial results.  The call and webcast will follow the ... Conference Call Details To access the live conference ... phone, please dial (877) 303-7208 from the United ...
Breaking Medicine Technology:genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4
... 27, 2012   VWR International, LLC , a global ... that it has signed an agreement to acquire ... in The Netherlands, France, Italy, Singapore, Malaysia and Vietnam. ... regulatory approval in Germany. With 30 years ...
... 2012  MetaStat, Inc. (OTCBB: MTST) announced today that ... patent applications and technology from the Albert Einstein ... license agreement covers U.S. Patent Application No. 12/998,237 ... Anti-Metastasis Treatment Efficacy"; inventors: Jeffrey Edward Segall, John ...
Cached Medicine Technology:VWR International, LLC Signs Agreement to Acquire basan Germany GmbH 2MetaStat, Inc. Executes Two New Licenses 2MetaStat, Inc. Executes Two New Licenses 3
(Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... (LMS) which continues to help healthcare agencies to ... help companies and agencies meet their accreditation ... with competency based training. , Healthcare administrators ... a few clicks of the mouse. Courses can ...
(Date:7/31/2014)... July 31, 2014 Current residents at ... treatment program in Flagstaff, AZ, learn to kayak safely ... equipment and paddle strokes in preparation for next week's ... "I think that [the kayaking course] teaches [residents] to ... struggle with in their early part of their sobriety," ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 Located ... the street from Macy’s, The Rothenberg Law Firm LLP has ... 450 Seventh Avenue. , The Rothenberg Law Firm has been ... move has been spurred by growth in the firm’s continued ... York. The firm’s New York office has a team of ...
(Date:7/31/2014)... Elk Grove Village, IL (PRWEB) July 31, 2014 ... hearing wellness solutions, today announced a new sponsorship ... events. Front and center are Etymotic’s hearing protection ... maintain high-fidelity while protecting against the harmful effects ... to kick off the sponsorship at the Drum ...
(Date:7/31/2014)... July 31, 2014 According to a ... Journal , Endo International, one of several manufacturing companies ... of transvaginal claims for $830 million (in re: American ... (MDL No. 2325). Melinda Helbock, Founder of The Law ... with the settlement and is pleased to see litigation ...
Breaking Medicine News(10 mins):Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 3Health News:Back2Basics Substance Abuse Residents Take Kayaking Class for the First Time 2Health News:Etymotic Research Becomes The Official Hearing Protection Sponsor Of DrumLine Battle 2Health News:San Diego Product Liability Firm Provides Commentary on the Latest Developments in Transvaginal Mesh Litigation 2
... measurements into account , TUESDAY, Sept. 1 (HealthDay News) -- ... & World Report list of best hospitals for heart ... failure, researchers say. , "If you really want to know ... mortality and readmission, you should look directly at government statistics ...
... flu strains , TUESDAY, Sept. 1 (HealthDay News) -- Fears ... this year may be unfounded, say researchers at the University ... the swine flu pandemic did not take a virulent turn ... did spread more rapidly than the other viruses, confirming the ...
... , , ... Board: MLSS), the recognized leader in advanced injection technologies, today ... Chairman of the Board, succeeding Leonard Osser who had previously ... has also served as the interim Chief Executive Officer since ...
... , WARSAW, Ind., Sept. 1 Zimmer Holdings, Inc. (NYSE: ... following investor conferences during the month of September: , , ... Mass., on September 9, 2009, at 11:30 a.m. Eastern Time; , ... September 14, 2009, at 8:35 a.m. Eastern Time; and , ...
... , CARDIFF, Calif., Sept. 1 ... http://www.jedimindinc.com ) announced today that their Medical Division is ... in wheelchairs. An estimated 1.6 million Americans residing outside of ... Interview Survey on Disability (NHIS-D). Jedi Mind,s Medical Division is ...
... , ... Information Association (DIA) will host Personalized Medicine: Biomarkers and Diagnostics in Drug Development, Regulatory ... , ... September 1, 2009 -- The Drug Information Association (DIA) will host ...
Cached Medicine News:Health News:Government Best Source for U.S. Hospital Data, Study Finds 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 2Health News:Swine Flu May Be Less Dangerous Than Predicted: Study 3Health News:Milestone Scientific Announces Key Leadership Changes 2Health News:Milestone Scientific Announces Key Leadership Changes 3Health News:Jedi Mind Medical Applications Division to Concentrate on Wheelchair Mobility Applications 2Health News:DIA Conference to Explore The Science and Scope of Personalized Medicine 2
... The Leica RM2235 is a robust ... of primarily biological specimens embedded in ... backlash-free precision micrometer feed system ensures ... even when sectioning harder tissues. The ...
... biomedical and industrial applications, the Leica SM2400 ... of applications in all laboratories where paraffin ... sectioned. Its sturdy construction lends it qualities ... features of the system, such as a ...
... Automatic microtome with vibrating blade for fixed and ... as for non-biological specimen in material science ... of blade amplitude between 0,1 and 1,2 mm ... parameters can be set independently from each other. ...
... EC 350 consists of two modular units. ... surface and reaches a temperature of -15C. ... reservoir, heated dispenser nozzle, heated work surface, ... separate heated compartments for molds and cassettes. ...
Medicine Products: